MGMT gene variants, temozolomide myelotoxicity and glioma risk. A concise literature survey including an illustrative case

Sadeleştirilmiş öğe sayfası
dc.contributor.authorAltinoz, Meric A.
dc.contributor.authorElmaci, Ilhan
dc.contributor.authorBolukbasi, Fatih Han
dc.contributor.authorEkmekci, Cumhur Gokhan
dc.contributor.authorYenmis, Guven
dc.contributor.authorSari, Ramazan
dc.contributor.authorSav, Aydin
dc.date.accessioned2025-10-16T15:27:44Z
dc.date.issued2017
dc.identifier.doi10.1080/1120009X.2017.1312752
dc.identifier.otherWOS:000404458000006
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/8565
dc.publisherTAYLOR \& FRANCIS LTD
dc.sourceJOURNAL OF CHEMOTHERAPY
dc.subjectMGMT
dc.subjectVariants
dc.subjectPolymorphisms
dc.subjectMyelotoxicity
dc.subjectCarcinogenesis
dc.subjectGlial tumour
dc.titleMGMT gene variants, temozolomide myelotoxicity and glioma risk. A concise literature survey including an illustrative case
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS